Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Acro Biotech, LLC · Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

190 daysmedian FDA review time
231 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K060355ACRO BIOTECH LLC RAPID MDMA URINE TEST, CATALOG MDMA0010000Acro Biotech, LLC2006-08-071750
K060354ACRO BIOTECH LLC RAPID BENZODIAZEPINE URINE TEST, CATALOG BZAcro Biotech, LLC2006-07-281650
K053037ACRO BIOTECH LLC RAPID OPIATES URINE TEST; CATALOG# OPI00100Acro Biotech, LLC2006-06-152310
K053033ACRO BIOTECH LLC RAPID METHAMPHETAMINE URINE TEST; CATALOG# Acro Biotech, LLC2006-06-062220
K053034ACRO BIOTECH LLC RAPID TETRAHYDROCANNABINOL URINE TEST; CATAAcro Biotech, LLC2006-06-062220
K053035ACRO BIOTECH LLC RAPID BENZOYLECGONINE URINE TEST; CATALOG# Acro Biotech, LLC2006-05-051900
K060353ACRO RAPID PHENCYCLIDINE URINE TEST, CATALOG PCP001000Acro Biotech, LLC2006-05-03790
K053032ACRO BIOTECH LLC RAPID AMPHETAMINE URINE TEST; CATALOG# AMP0Acro Biotech, LLC2006-02-091050

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda